Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 11.88
- Piotroski Score 8.00
- Grade Sector Perform
- Symbol (ABCM)
- Company Abcam plc
- Price $23.99
- Changes Percentage (0.04%)
- Change $0.01
- Day Low $23.98
- Day High $24.00
- Year High $25.32
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.
- Last Earnings N/A
- Ex-Dividend for 5/16 Dividend 03/19/2020
- Dividend Payable N/A
- Today N/A
- Next Earnings (Estimated) 08/31/2023
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating N/A
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.01
- Trailing P/E Ratio 2399
- Forward P/E Ratio 2399
- P/E Growth 2399
- Net Income $-8,500,000
